Literature DB >> 2746048

Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.

J Schwenk1, J Makovitzky.   

Abstract

The expression of the gastrointestinal cancer-associated antigens CA 19-9 and CA-50 was studied in 43 ductal pancreatic carcinomas, 1 mucinous cystadenoma, 1 signet-ring-cell carcinoma, 42 pancreata with chronic pancreatitis, and 10 normal fetal and adult pancreata. The anti-CA-50 antibody gave a more intense and more uniformly distributed staining of the ductal epithelial cells than the anti-CA 19-9 antibody. Both antigens, however, exhibited the same staining pattern of ductal epithelial cells in normal pancreas and chronic pancreatitis. Well differentiated carcinomas showed a predominantly membrane-bound antigen expression, whereas moderately and poorly differentiated carcinomas gave a more diffuse cytoplasmic staining. Epithelial dysplasia could not be differentiated by the staining pattern from normal, hyperplastic, metaplastic, or neoplastic cells. The immunohistochemical reaction with these anticarbohydrate antibodies, therefore, does not allow a qualitative discrimination between chronic pancreatitis and pancreatic carcinoma. CA 19-9, which expression depends on the Lewis gene, was negative in two patients with Le(a-b-) phenotype. Although anti-CA-50 antibody was reactive with the cancer cells of these 2 patients, the staining was weak and heterogenous.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2746048     DOI: 10.1007/bf02925701

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  20 in total

1.  CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis.

Authors:  R Farini; C Fabris; P Bonvicini; A Piccoli; G del Favero; R Venturini; A Panucci; R Naccarato
Journal:  Eur J Cancer Clin Oncol       Date:  1985-04

2.  Differences in ultrastructural organization of amyloid as revealed by sensitivity or resistance to induced proteolysis.

Authors:  G Romhányi
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972

3.  Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody.

Authors:  O Nilsson; J E Månsson; L Lindholm; J Holmgren; L Svennerholm
Journal:  FEBS Lett       Date:  1985-03-25       Impact factor: 4.124

4.  Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.

Authors:  J Holmgren; L Lindholm; B Persson; T Lagergård; O Nilsson; L Svennerholm; C M Rudenstam; B Unsgaard; F Yngvason; S Pettersson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

5.  A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.

Authors:  J L Magnani; B Nilsson; M Brockhaus; D Zopf; Z Steplewski; H Koprowski; V Ginsburg
Journal:  J Biol Chem       Date:  1982-12-10       Impact factor: 5.157

6.  Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants.

Authors:  M Herlyn; J W Shen; H F Sears; C I Civin; H L Verrill; E M Goldberg; H Koprowski
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

7.  Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera.

Authors:  M Dietel; H Arps; R Klapdor; S Müller-Hagen; M Sieck; L Hoffmann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

8.  Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.

Authors:  C Haglund; J Lindgren; P J Roberts; S Nordling
Journal:  Int J Cancer       Date:  1986-12-15       Impact factor: 7.396

9.  The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study.

Authors:  J Makovitzky
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1986

10.  Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.

Authors:  C Haglund; J Lindgren; P J Roberts; S Nordling
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

View more
  8 in total

1.  Normal colon of Sprague-Dawley rats. An immunohistochemical study.

Authors:  J D Shetye; C A Rubio; H T Mellstedt
Journal:  Anat Embryol (Berl)       Date:  1992

2.  Comparative study on the expression of the blood group antigens Le a, Le b, Le x, Le y and the carbohydrate antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.

Authors:  J Schwenk; J Makovitzky
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 3.  Circulating blood group related carbohydrate antigens as tumour markers.

Authors:  T F Orntoft; E Bech
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

4.  Cancer-associated tumour markers CA 19-9 and CA-50 in patients with pancreatic cancer with special reference to the Lewis blood cell status.

Authors:  P Masson; B Pålsson; A Andrén-Sandberg
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

5.  Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature.

Authors:  Tsubasa Watanabe; Elke Firat; Jutta Scholber; Simone Gaedicke; Corinne Heinrich; Ren Luo; Nicolas Ehrat; Gabriele Multhoff; Annette Schmitt-Graeff; Anca-Ligia Grosu; Amir Abdollahi; Jessica C Hassel; Dagmar von Bubnoff; Frank Meiss; Gabriele Niedermann
Journal:  Cancer Immunol Immunother       Date:  2020-04-29       Impact factor: 6.968

6.  Radiation-activated secretory proteins of Scgb1a1 + club cells increase the efficacy of immune checkpoint blockade in lung cancer.

Authors:  Yi Ban; Geoffrey J Markowitz; Yue Zou; Divya Ramchandani; Jeffrey Kraynak; Jianting Sheng; Sharrell B Lee; Stephen T C Wong; Nasser K Altorki; Dingcheng Gao; Vivek Mittal
Journal:  Nat Cancer       Date:  2021-09-20

7.  Glycan-Based Near-infrared Fluorescent (NIRF) Imaging of Gastrointestinal Tumors: a Preclinical Proof-of-Concept In Vivo Study.

Authors:  Ruben D Houvast; Victor M Baart; Shadhvi S Bhairosingh; Robert A Cordfunke; Jia Xin Chua; Mireille Vankemmelbeke; Tina Parsons; Peter J K Kuppen; Lindy G Durrant; Alexander L Vahrmeijer; Cornelis F M Sier
Journal:  Mol Imaging Biol       Date:  2020-08-11       Impact factor: 3.488

8.  Discovery and 3D imaging of a novel ΔNp63-expressing basal cell type in human pancreatic ducts with implications in disease.

Authors:  Sandrina Martens; Katarina Coolens; Mathias Van Bulck; Joan Casamitjana; Angel Fernandez Ruiz; Tatjana Arsenijevic; Abdessamad El Kaoutari; Jaime Martinez de Villareal; Hediel Madhloum; Farzad Esni; Yves Heremans; Gunter Leuckx; Harry Heimberg; Luc Bouwens; Patrick Jacquemin; Diedert Luc De Paep; Peter In't Veld; Nicky D'Haene; Christelle Bouchart; Nelson Dusetti; Jean-Luc Van Laethem; Wim Waelput; Pierre Lefesvre; Francisco X Real; Meritxell Rovira; Ilse Rooman
Journal:  Gut       Date:  2021-07-30       Impact factor: 31.793

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.